SPRAY III (Sativex® for Pain
Research in Advanced malignancY)
is a clinical research study to determine if the investigational medication
Sativex® (nabiximols) is effective in managing chronic cancer pain.
An investigational medication is one that has not been approved yet by your country.
Sativex® has been approved in Canada as an add-on treatment for
pain in patients with advanced cancer.
Sativex® comes in the form of a mouth spray taken by spraying it
in your mouth on the inside of your cheeks. More details on how to take this study
medication will be provided to you if you decide to participate in the SPRAY III
If you reside in the United States, you may use our online screener to find out
if you or someone you know may be eligible to participate in the SPRAY III study.
You will also be able to find the SPRAY III study site locations to find the one
closest to you or the potential participant.